Neuroendocrine gastric carcinoma expressing somatostatin: A highly malignant, rare tumor

doi:10.3748/wjg.v12.i24.3944

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2543)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

238

HTML

2179

Figures (1-2)

126

Sum=2543

Jun 28, 2006 (publication date) through May 2, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jun 28, 2006; 12(24): 3944-3947
Published online Jun 28, 2006. doi: 10.3748/wjg.v12.i24.3944

Full Size Figure Download Figure

Figure 2 Immunohistochemistry of the neuroendocrine gastric carcinoma showing intense and diffuse somatostatin-positive imunoreactivity in the neoplastic cells (Immunoperoxidase, primary antibody anti-human somatostatin-code A0566-Dako A/S^®, Copenhagen, Denmark, original magnification, × 400).

Citation: Waisberg J, Matos LL, Mader AMAA, Pezzolo S, Eher EM, Capelozzi VL, Speranzini MB. Neuroendocrine gastric carcinoma expressing somatostatin: A highly malignant, rare tumor. World J Gastroenterol 2006; 12(24): 3944-3947
URL: https://www.wjgnet.com/1007-9327/full/v12/i24/3944.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i24.3944